MGAT5 and diabetic cardiomyopathy: Thus, to determine if GnT-V knockdown inhibited cardiac hypertrophy in diabetic cardiomyopathy via integrin β1, we carried out in vitro experiments using H9C2 cells and an inhibitor (BTT-3033) against integrin.